Table of Content

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends
4. Impact of COVID-19 on Global Digital Vaccine Market
5. Clinical Trial Analysis
6. Patent Analysis
7. Voice of Customer
8. Global Digital Vaccine Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Device Type (Smartphones, Tablets, Others)
8.2.2. By Application (Diabetes, Infectious Diseases, Cardiovascular Diseases, Others)
8.2.3. By Region
8.2.4. By Company (2022)
9. Asia-Pacific Digital Vaccine Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Device Type (Smartphones, Tablets, Others)
9.2.2. By Application (Diabetes, Infectious Diseases, Cardiovascular Diseases, Others)
9.2.3. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. China Digital Vaccine Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Device Type
9.3.1.2.2. By Application
9.3.2. Australia Digital Vaccine Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Device Type
9.3.2.2.2. By Application
9.3.3. China Digital Vaccine Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Device Type
9.3.3.2.2. By Application
9.3.4. Japan Digital Vaccine Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Device Type
9.3.4.2.2. By Application
9.3.5. Thailand Digital Vaccine Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Device Type
9.3.5.2.2. By Application
10. North America Digital Vaccine Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Device Type (Smartphones, Tablets, Others)
10.2.2. By Application (Diabetes, Infectious Diseases, Cardiovascular Diseases, Others)
10.2.3. By Country
10.3. North America: Country Analysis
10.3.1. United States Digital Vaccine Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Device Type
10.3.1.2.2. By Application
10.3.2. Canada Digital Vaccine Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Device Type
10.3.2.2.2. By Application
10.3.3. Mexico Digital Vaccine Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Device Type
10.3.3.2.2. By Application
11. Europe Digital Vaccine Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Device Type (Smartphones, Tablets, Others)
11.2.2. By Application (Diabetes, Infectious Diseases, Cardiovascular Diseases, Others)
11.2.3. By Country
11.3. Europe: Country Analysis
11.3.1. France Digital Vaccine Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Device Type
11.3.1.2.2. By Application
11.3.2. United Kingdom Digital Vaccine Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Device Type
11.3.2.2.2. By Application
11.3.3. Italy Digital Vaccine Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Device Type
11.3.3.2.2. By Application
11.3.4. Denmark Digital Vaccine Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Device Type
11.3.4.2.2. By Application
11.3.5. Germany Digital Vaccine Market Outlook
11.3.5.1. Market Size & Forecast
11.3.5.1.1. By Value
11.3.5.2. Market Share & Forecast
11.3.5.2.1. By Device Type
11.3.5.2.2. By Application
12. Middle East and Africa Digital Vaccine Market Outlook
12.1. Market Size & Forecast
12.1.1. By Value
12.2. Market Share & Forecast
12.2.1. By Device Type (Smartphones, Tablets, Others)
12.2.2. By Application (Diabetes, Infectious Diseases, Cardiovascular Diseases, Others)
12.2.3. By Country
12.3. MEA: Country Analysis
12.3.1. South Africa Digital Vaccine Market Outlook
12.3.1.1. Market Size & Forecast
12.3.1.1.1. By Value
12.3.1.2. Market Share & Forecast
12.3.1.2.1. By Device Type
12.3.1.2.2. By Application
12.3.2. Nigeria Digital Vaccine Market Outlook
12.3.2.1. Market Size & Forecast
12.3.2.1.1. By Value
12.3.2.2. Market Share & Forecast
12.3.2.2.1. By Device Type
12.3.2.2.2. By Application
12.3.3. UAE Digital Vaccine Market Outlook
12.3.3.1. Market Size & Forecast
12.3.3.1.1. By Value
12.3.3.2. Market Share & Forecast
12.3.3.2.1. By Device Type
12.3.3.2.2. By Application
12.3.4. Saudi Arabia Digital Vaccine Market Outlook
12.3.4.1. Market Size & Forecast
12.3.4.1.1. By Value
12.3.4.2. Market Share & Forecast
12.3.4.2.1. By Device Type
12.3.4.2.2. By Application
13. South America Digital Vaccine Market Outlook
13.1. Market Size & Forecast
13.1.1. By Value
13.2. Market Share & Forecast
13.2.1. By Device Type (Smartphones, Tablets, Others)
13.2.2. By Application (Diabetes, Infectious Diseases, Cardiovascular Diseases, Others)
13.2.3. By Country
13.3. South America: Country Analysis
13.3.1. Argentina Digital Vaccine Market Outlook
13.3.1.1. Market Size & Forecast
13.3.1.1.1. By Value
13.3.1.2. Market Share & Forecast
13.3.1.2.1. By Device Type
13.3.1.2.2. By Application
13.3.2. Brazil Digital Vaccine Market Outlook
13.3.2.1. Market Size & Forecast
13.3.2.1.1. By Value
13.3.2.2. Market Share & Forecast
13.3.2.2.1. By Device Type
13.3.2.2.2. By Application
13.3.3. Colombia Digital Vaccine Market Outlook
13.3.3.1. Market Size & Forecast
13.3.3.1.1. By Value
13.3.3.2. Market Share & Forecast
13.3.3.2.1. By Device Type
13.3.3.2.2. By Application
14. Market Dynamics
14.1. Drivers
14.2. Challenges
15. Market Trends & Developments
15.1. Product Launches
15.2. Mergers & Acquisitions
15.3. Technological Advancements
16. Global Digital Vaccine Market: SWOT Analysis
17. Competitive Landscape
17.1. FriendsLearn, Inc.
17.2. Klein Buendel, Inc
17.3. Evidation Health, Inc.
17.4. Atos SE
17.5. oVRcome
18. Strategic Recommendation
19. About Us & Disclaimer



List of Figures

Figure 1: Global Digital Vaccine Market Size, By Value (USD Million), 2018-2028F
Figure 2: Global Digital Vaccine Market Share, By Device Type, By Value, 2018-2028F
Figure 3: Global Digital Vaccine Market Share, By Application, By Value, 2018-2028F
Figure 4: Global Digital Vaccine Market Share, By Region, By Value, 2018-2028F
Figure 5: Global Digital Vaccine Market Map, By Device Type, Market Size (USD Million) & Growth Rate (%), 2022
Figure 6: Global Digital Vaccine Market Map, By Application, Market Size (USD Million) & Growth Rate (%), 2022
Figure 7: Global Digital Vaccine Market Map, By Region, Market Size (USD Million) & Growth Rate (%), 2022
Figure 8: Asia Pacific Digital Vaccine Market Size, By Value (USD Million), 2018-2028F
Figure 9: Asia Pacific Digital Vaccine Market Share, By Device Type, By Value, 2018-2028F
Figure 10: Asia Pacific Digital Vaccine Market Share, By Application, By Value, 2018-2028F
Figure 11: Asia Pacific Digital Vaccine Market Share, By Country, By Value, 2018-2028F
Figure 12: India Digital Vaccine Market Size, By Value (USD Million), 2018-2028F
Figure 13: Share of Respondents with Diabetes across India (%), 2018-2021
Figure 14: India Digital Vaccine Market Share, By Device Type, By Value, 2018-2028F
Figure 15: India Digital Vaccine Market Share, By Application, By Value, 2018-2028F
Figure 16: Australia Digital Vaccine Market Size, By Value (USD Million), 2018-2028F
Figure 17: Australia Diabetes Estimates in People of Age Group 20-79 Years (in Thousands)
Figure 18: Australia Digital Vaccine Market Share, By Device Type, By Value, 2018-2028F
Figure 19: Australia Digital Vaccine Market Share, By Application, By Value, 2018-2028F
Figure 20: China Digital Vaccine Market Size, By Value (USD Million), 2018-2028F
Figure 21: Percentage of New Cancer Cases in China, Both Sexes, All Ages, 2020
Figure 22: China Digital Vaccine Market Share, By Device Type, By Value, 2018-2028F
Figure 23: China Digital Vaccine Market Share, By Application, By Value, 2018-2028F
Figure 24: Japan Digital Vaccine Market Size, By Value (USD Million), 2018-2028F
Figure 25: Japan Research & Development Expenditure As a Percentage of GDP, 2017-2020
Figure 26: Japan Digital Vaccine Market Share, By Device Type, By Value, 2018-2028F
Figure 27: Japan Digital Vaccine Market Share, By Application, By Value, 2018-2028F
Figure 28: Thailand Digital Vaccine Market Size, By Value (USD Million), 2018-2028F
Figure 29: People with Diabetes in Thailand, in 1,000s
Figure 30: Thailand Digital Vaccine Market Share, By Device Type, By Value, 2018-2028F
Figure 31: Thailand Digital Vaccine Market Share, By Application, By Value, 2018-2028F
Figure 32: North America Digital Vaccine Market Size, By Value (USD Million), 2018-2028F
Figure 33: North America Digital Vaccine Market Share, By Device Type, By Value, 2018-2028F
Figure 34: North America Digital Vaccine Market Share, By Application, By Value, 2018-2028F
Figure 35: North America Digital Vaccine Market Share, By Country, By Value, 2018-2028F
Figure 36: United States Digital Vaccine Market Size, By Value (USD Million), 2018-2028F
Figure 37: New Cancer Cases Reported in the United States in 2020, Both Sexes, All Ages
Figure 38: United States Digital Vaccine Market Share, By Device Type, By Value, 2018-2028F
Figure 39: United States Digital Vaccine Market Share, By Application, By Value, 2018-2028F
Figure 40: Canada Digital Vaccine Market Size, By Value (USD Million), 2018-2028F
Figure 41: Total Health Research Expenditure in Canada (USD), 2017-2021
Figure 42: Canada Digital Vaccine Market Share, By Device Type, By Value, 2018-2028F
Figure 43: Canada Digital Vaccine Market Share, By Application, By Value, 2018-2028F
Figure 44: Mexico Digital Vaccine Market Size, By Value (USD Million), 2018-2028F
Figure 45: People with Diabetes in Mexico, in 1,000s
Figure 46: Mexico Digital Vaccine Market Share, By Device Type, By Value, 2018-2028F
Figure 47: Mexico Digital Vaccine Market Share, By Application, By Value, 2018-2028F
Figure 48: Europe Digital Vaccine Market Size, By Value (USD Million), 2018-2028F
Figure 49: Europe Digital Vaccine Market Share, By Device Type, By Value, 2018-2028F
Figure 50: Europe Digital Vaccine Market Share, By Application, By Value, 2018-2028F
Figure 51: Europe Digital Vaccine Market Share, By Country, By Value, 2018-2028F
Figure 52: France Digital Vaccine Market Size, By Value (USD Million), 2018-2028F
Figure 53: Share of the French population who developed depressive symptoms in May 2020, by gender
Figure 54: France Digital Vaccine Market Share, By Device Type, By Value, 2018-2028F
Figure 55: France Digital Vaccine Market Share, By Application, By Value, 2018-2028F
Figure 56: United Kingdom Digital Vaccine Market Size, By Value (USD Million), 2018-2028F
Figure 57: Anxiety Levels of People in United Kingdom
Figure 58: United Kingdom Digital Vaccine Market Share, By Device Type, By Value, 2018-2028F
Figure 59: United Kingdom Digital Vaccine Market Share, By Application, By Value, 2018-2028F
Figure 60: Italy Digital Vaccine Market Size, By Value (USD Million), 2018-2028F
Figure 61: Number of Individuals Suffering from Diabetes in Italy, 2017-2020 (In Thousands)
Figure 62: Italy Digital Vaccine Market Share, By Device Type, By Value, 2018-2028F
Figure 63: Italy Digital Vaccine Market Share, By Application, By Value, 2018-2028F
Figure 64: Denmark Digital Vaccine Market Size, By Value (USD Million), 2018-2028F
Figure 65: Number of Individuals Suffering from Type 2 Diabetes in Denmark, 2018-2021
Figure 66: Denmark Digital Vaccine Market Share, By Device Type, By Value, 2018-2028F
Figure 67: Denmark Digital Vaccine Market Share, By Application, By Value, 2018-2028F
Figure 68: Germany Digital Vaccine Market Size, By Value (USD Million), 2018-2028F
Figure 69: Germany Research & Development Expenditure as a Percentage of GDP
Figure 70: Germany Digital Vaccine Market Share, By Device Type, By Value, 2018-2028F
Figure 71: Germany Digital Vaccine Market Share, By Application, By Value, 2018-2028F
Figure 72: Middle East & Africa Digital Vaccine Market Size, By Value (USD Million), 2018-2028F
Figure 73: Middle East & Africa Digital Vaccine Market Share, By Device Type, By Value, 2018-2028F
Figure 74: Middle East & Africa Digital Vaccine Market Share, By Application, By Value, 2018-2028F
Figure 75: Middle East & Africa Digital Vaccine Market Share, By Country, By Value, 2018-2028F
Figure 76: South Africa Digital Vaccine Market Size, By Value (USD Million), 2018-2028F
Figure 77: Percentage of New Cancer Cases in South Africa, Both Sexes, All Ages, 2020
Figure 78: South Africa Digital Vaccine Market Share, By Device Type, By Value, 2018-2028F
Figure 79: South Africa Digital Vaccine Market Share, By Application, By Value, 2018-2028F
Figure 80: Nigeria Digital Vaccine Market Size, By Value (USD Million), 2018-2028F
Figure 81: People with Diabetes in Nigeria, in 1,000s
Figure 82: Nigeria Digital Vaccine Market Share, By Device Type, By Value, 2018-2028F
Figure 83: Nigeria Digital Vaccine Market Share, By Application, By Value, 2018-2028F
Figure 84: UAE Digital Vaccine Market Size, By Value (USD Million), 2018-2028F
Figure 85: Outpatient Healthcare Expenditure in UAE (USD Billion), 2017-2022
Figure 86: UAE Digital Vaccine Market Share, By Device Type, By Value, 2018-2028F
Figure 87: UAE Digital Vaccine Market Share, By Application, By Value, 2018-2028F
Figure 88: Saudi Arabia Digital Vaccine Market Size, By Value (USD Million), 2018-2028F
Figure 89: Percentage of New Cancer Cases in Saudi Arabia, Both Sexes, All Ages, 2020
Figure 90: Saudi Arabia Digital Vaccine Market Share, By Device Type, By Value, 2018-2028F
Figure 91: Saudi Arabia Digital Vaccine Market Share, By Application, By Value, 2018-2028F
Figure 92: South America Digital Vaccine Market Size, By Value (USD Million), 2018-2028F
Figure 93: South America Digital Vaccine Market Share, By Device Type, By Value, 2018-2028F
Figure 94: South America Digital Vaccine Market Share, By Application, By Value, 2018-2028F
Figure 95: South America Digital Vaccine Market Share, By Country, By Value, 2018-2028F
Figure 96: Argentina Digital Vaccine Market Size, By Value (USD Million), 2018-2028F
Figure 97: Percentage of New Cancer Cases in Argentina, Both Sexes, All Ages, 2020
Figure 98: Argentina Digital Vaccine Market Share, By Device Type, By Value, 2018-2028F
Figure 99: Argentina Digital Vaccine Market Share, By Application, By Value, 2018-2028F
Figure 100: Brazil Digital Vaccine Market Size, By Value (USD Million), 2018-2028F
Figure 101: People with Diabetes in Brazil, in 1,000s
Figure 102: Brazil Digital Vaccine Market Share, By Device Type, By Value, 2018-2028F
Figure 103: Brazil Digital Vaccine Market Share, By Application, By Value, 2018-2028F
Figure 104: Colombia Digital Vaccine Market Size, By Value (USD Million), 2018-2028F
Figure 105: Percentage of New Cancer Cases in Colombia, Both Sexes, All Ages, 2020
Figure 106: Colombia Digital Vaccine Market Share, By Device Type, By Value, 2018-2028F
Figure 107: Colombia Digital Vaccine Market Share, By Application, By Value, 2018-2028F

List of Tables

Table 1: Digital Vaccine, Clinical Trial Analysis
Table 2: Global Cancer Statistics, 2020
Table 3: Asia Pacific Cancer Statistics, 2020
Table 4: North America Cancer Statistics, 2020
Table 5: Europe Cancer Statistics, 2020
Table 6: Middle East & Africa Cancer Statistics, 2020
Table 7: South America Cancer Statistics, 2020